RankAlpha logo
Back to Rankings

RCKT

RocketD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Curated Events
25
Active
Recent Headlines
0
New
Recent news sentiment
0.0
30-day score
Company
-
30-day
Macro
-
30-day
Pulse
-
30-day
Weekly research
-
10-day

Curated events

High impact
74
conflict / systemic issuecompany updateSentiment +22
Source
Systemic monitor
Decided
2026-09-25
Rocket Lab CEO Puts Iridium Deal Alongside SpaceX And Amazons Spectrum Bets: You Cant Just Magic Up Spectrum

The headline frames Rocket Lab’s Iridium deal as a strategic bet on scarce spectrum, supporting a modestly positive read-through for RKLB and IRDM. The payload contains only a headline, so the deal commentary and its implications cannot be assessed in depth.

View event details24 more curated

Sentiment decomposition

0.0
30-day score
Company-55%
Macro-30%
Pulse-15%
Weekly research-10-day
Company, Macro, and Pulse form the existing 30-day artifact blend. Weekly research is tracked separately for 10 days and can contribute at most 10% of the sentiment pillar when live mode is enabled.

Recent headlines

No supplemental ticker headlines stored yet

We are still collecting relevant articles for RCKT. Curated events highlight the most material developments impacting this ticker right now.

Check curated eventsOpen full news archive
As of 2026-09-25 • Updated scheduledSource: News desk